|
Volumn 26, Issue 6, 2001, Pages 480-483
|
Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIPSORIASIS AGENT;
CYCLOSPORIN;
HYDROXYUREA;
METHOTREXATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAXOZANE;
RETINOID;
SALAZOSULFAPYRIDINE;
UNCLASSIFIED DRUG;
ABDOMINAL CRAMP;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE CONTROL;
DISEASE SEVERITY;
DRUG INDUCED DISEASE;
DRUG MEGADOSE;
DRUG TOLERANCE;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
NEPHROTOXICITY;
PRIORITY JOURNAL;
PSORIASIS;
PSORIATIC ARTHRITIS;
PUVA;
RISK;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
CHRONIC DISEASE;
CYCLOSPORINE;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MYCOPHENOLIC ACID;
PSORIASIS;
TREATMENT OUTCOME;
|
EID: 0034797035
PISSN: 03076938
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2230.2001.00870.x Document Type: Article |
Times cited : (44)
|
References (19)
|